Virological and Immunological Antiretroviral Treatment Failure and Predictors Among HIV Positive Adult and Adolescent Clients in Southeast Ethiopia

References

• Assebe LF, Negussie EK, Jbaily A, Tolla MTT, Johansson KA. Financial burden of HIV and TB among patients in Ethiopia: a cross-sectional survey. BMJ Open. 2020;10(6):e036892. doi:10.1136/bmjopen-2020-036892
   PubMed Web of Science ®Google Scholar
• The global HIV/AIDS epidemic 2022. Available from: https://www.hiv.gov/hiv-basics/overview/data-and-trends/global-statistics. Accessed January 28, 2022.
   Google Scholar
• Platform WHD. Estimated number of people (all ages) living with HIV; 2020. Available from: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/estimated-number-of-people-(all-ages)-living-with-hiv. Accessed November 20, 2020.
   Google Scholar
• Mirkuzie AH, Ali S, Abate E, Worku A, Misganaw A. Progress towards the 2020 Fast Track HIV/AIDS reduction targets in Ethiopia comparing with neighboring countries and across ages; using Global Burden of Diseases 2017 data. 2020.
   Google Scholar
• Ethiopia country operational plan COP 2021 strategic direction summary final; 2021 Available from: https://www.state.gov/wp-content/uploads/2021/09/Ethiopia_SDS_Final-Public_Aug-11-2021.pdf. Accessed January 28, 2022.
   Google Scholar
• Vitoria M, Granich R, Gilks CF, et al. The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives. Am J Clin Pathol. 2009;131(6):844–848. doi:10.1309/AJCP5XHDB1PNAEYT
   PubMed Web of Science ®Google Scholar
• Assemie MA, Alene M, Ketema DB, Mulatu S. Treatment failure and associated factors among first line patients on highly active antiretroviral therapy in Ethiopia: a systematic review and meta-analysis. Glob Health Res Policy. 2019;4(1):1–10. doi:10.1186/s41256-019-0120-4
   Google Scholar
• WHO. Ethiopia HIV country profile 2020. Available from: https://cfs.hivci.org/. Accessed January 28, 2022.
   Google Scholar
• Hailu GG, Hagos DG, Hagos AK, Wasihun AG, Dejene TA. Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia. PLoS One. 2018;13(5):e0196259. doi:10.1371/journal.pone.0196259
   PubMed Web of Science ®Google Scholar
• Mulisa D, Tesfa M, Kassa GM, Tolossa T. Determinants of first line antiretroviral therapy treatment failure among adult patients on ART at central Ethiopia: un-matched case control study. BMC Infect Dis. 2019;19(1):1024. doi:10.1186/s12879-019-4651-6
   PubMed Web of Science ®Google Scholar
• Enderis BO, Hebo SH, Debir MK, Sidamo NB, Shimber MS. Predictors of time to first line antiretroviral treatment failure among adult patients living with HIV in public health facilities of Arba Minch Town, Southern Ethiopia. Ethiop J Health Sci. 2019;29(2):175–186. doi:10.4314/ejhs.v29i2.4
   PubMed Web of Science ®Google Scholar
• Niemeyer K, King A, Mengistu S, Hennig N. Predictors for antiretroviral therapy (ART) failure in an urban HIV/AIDS clinic in Addis Ababa, Ethiopia. Lancet Glob Health. 2016;4:S6. doi:10.1016/S2214-109X(16)30011-0
   Web of Science ®Google Scholar
• WHO. WHO Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. Geneva, Switzerland: WHO; 2013.
   Google Scholar
• Rutherford GW, Anglemyer A, Easterbrook PJ, et al. Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure. Aids. 2014;28:S161–S9. doi:10.1097/QAD.0000000000000236
   PubMed Web of Science ®Google Scholar
• Haile D, Takele A, Gashaw K, Demelash H, Nigatu D. Predictors of treatment failure among adult antiretroviral treatment (ART) clients in Bale zone hospitals, south eastern Ethiopia. PLoS One. 2016;11(10):e0164299. doi:10.1371/journal.pone.0164299
   PubMed Web of Science ®Google Scholar
• Rawizza HE, Chaplin B, Meloni ST, et al. Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings. Clin Infect Dis. 2011;53(12):1283–1290. doi:10.1093/cid/cir729
   PubMed Web of Science ®Google Scholar
• World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. World Health Organization; 2016.
   Google Scholar
• Misgena DK. The pattern of immunologic and virologic responses to Highly Active Antiretroviral Treatment (HAART): does success bring further challenges? Ethiop J Health Dev. 2011;25(1):61–70. doi:10.4314/ejhd.v25i1.69853
   Web of Science ®Google Scholar
• WHO. WHO March 2014 Supplement to the 2013 Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. WHO; 2014.
   Google Scholar
• Ayele G, Tessema B, Amsalu A, Ferede G, Yismaw G. Prevalence and associated factors of treatment failure among HIV/AIDS patients on HAART attending University of Gondar Referral Hospital Northwest Ethiopia. BMC Immunol. 2018;19(1):37. doi:10.1186/s12865-018-0278-4
   PubMed Web of Science ®Google Scholar
• Okatch H, Beiter K, Eby J, et al. Brief report: apparent antiretroviral overadherence by pill count is associated with HIV treatment failure in adolescents. J Acquir Immune Deficiency Syndr. 2016;72(5):542–545. doi:10.1097/QAI.0000000000000994
   PubMed Web of Science ®Google Scholar
• Wendie TF, Workneh BD. Prevalence and predictors of virological failure among adults living with HIV in South Wollo Zone, Northeast Ethiopia: a retrospective cohort study. HIV/AIDS. 2020;12:393.
   Google Scholar
• Teshome W, Tefera A. Detection of immunological treatment failure among HIV infected patients in Ethiopia: a retrospective cohort study. BMC Immunol. 2015;16(1):55. doi:10.1186/s12865-015-0120-1
   PubMed Web of Science ®Google Scholar
• Feleke R, Geda B, Teji Roba K, Weldegebreal F. Magnitude of antiretroviral treatment failure and associated factors among adult HIV-positive patients in Harar public hospitals, Eastern Ethiopia. SAGE Open Med. 2020;8:2050312120906076. doi:10.1177/2050312120906076
   Web of Science ®Google Scholar
• Nega J, Taye S, Million Y, Rodrigo C, Eshetie S. Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia. AIDS Res Ther. 2020;17(1):1–9. doi:10.1186/s12981-020-00294-z
   PubMed Web of Science ®Google Scholar
• Vanobberghen FM, Kilama B, Wringe A, et al. Immunological failure of first-line and switch to second-line antiretroviral therapy among HIV-infected persons in Tanzania: analysis of routinely collected national data. Trop Med Int Health. 2015;20(7):880–892. doi:10.1111/tmi.12507
   PubMed Web of Science ®Google Scholar
• Huang P, Tan J, Ma W, et al. Outcomes of antiretroviral treatment in HIV-infected adults: a dynamic and observational cohort study in Shenzhen, China, 2003–2014. BMJ open. 2015;5(5):e007508–e007508. doi:10.1136/bmjopen-2014-007508
   PubMed Web of Science ®Google Scholar
• Shet A, Neogi U, Kumarasamy N, DeCosta A, Shastri S, Rewari BB. Virological efficacy with first‐line antiretroviral treatment in India: predictors of viral failure and evidence of viral resuppression. Trop Med Int Health. 2015;20(11):1462–1472. doi:10.1111/tmi.12563
   PubMed Web of Science ®Google Scholar
• Demsie DG, Bantie AT, Allene MD, Alema NM, Gebrie D. Antiretroviral treatment failure among HIV-positive adults taking first-line therapy and associated risk factors at Adigrat General hospital, Adigart, Ethiopia 2019: a cross sectional study. Int J Surg Open. 2020;26:16–21. doi:10.1016/j.ijso.2020.08.001
   Web of Science ®Google Scholar
• Gesesew HA, Ward P, Woldemichael K, Mwanri L. Immunological failure in HIV-infected adults from 2003 to 2015 in Southwest Ethiopia: a retrospective cohort study. BMJ open. 2018;8(8):e017413. doi:10.1136/bmjopen-2017-017413
   PubMed Web of Science ®Google Scholar
• Lenjiso GA, Endale BS, Bacha YD. Clinical and immunological failure among HIV-positive adults taking first-line antiretroviral therapy in Dire Dawa, eastern Ethiopia. BMC Public Health. 2019;19(1):771. doi:10.1186/s12889-019-7078-5
   PubMed Web of Science ®Google Scholar
• Palladino C, Briz V, Bellón JM, et al. Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique. PLoS One. 2013;8(12):e82718. doi:10.1371/journal.pone.0082718
   PubMed Web of Science ®Google Scholar
• Gross R, Yip B, Re VL, et al. A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis. 2006;194(8):1108–1114. doi:10.1086/507680
   PubMed Web of Science ®Google Scholar
• Jorge AR, Jorge PB, Elsa GL, et al. Risk factors associated with virologic failure in HIV-infected patients receiving antiretroviral therapy at a public hospital in Peru. Revista Chilena de Infectologia. 2013;30(1):42. doi:10.4067/S0716-10182013000100006
   PubMed Web of Science ®Google Scholar
• Musa BM, Coker M, Bussell S, et al. Long-term outcomes of antiretroviral therapy in an adult HIV program: a 10-year retrospective cohort study in Kano, Nigeria. Ann Saudi Med. 2015;35(4):303–311. doi:10.5144/0256-4947.2015.303
   PubMed Web of Science ®Google Scholar
• Estill J, Kerr CC, Blaser N, et al. The Effect of Monitoring Viral Load and Tracing Patients Lost to Follow-Up on the Course of the HIV Epidemic in Malawi: A Mathematical Model. Open Forum Infectious Diseases. Oxford University Press US; 2018.
   Google Scholar
• Asgedom SW, Maru M, Berihun B, Gidey K, Niriayo YL, Atey TM. Immunologic and clinical failure of antiretroviral therapy in people living with human immunodeficiency virus within two years of treatment. Biomed Res Int. 2020;2020:1–8. doi:10.1155/2020/5474103
   Web of Science ®Google Scholar
• Bayou B, Sisay A, Kumie A. Assessment of the magnitude and associated factors of immunological failure among adult and adolescent HIV-infected patients in St. Luke and Tulubolo Hospital, Oromia Region. Ethiop Pan Afri Med J. 2015;21(1):291.
   PubMedGoogle Scholar
• Yirdaw KD, Hattingh S, Paraskevis D. Prevalence and predictors of immunological failure among HIV patients on HAART in Southern Ethiopia. PLoS One. 2015;10(5):e0125826. doi:10.1371/journal.pone.0125826
   PubMed Web of Science ®Google Scholar
• Ferreyra C, Yun O, Eisenberg N, et al. Evaluation of clinical and immunological markers for predicting virological failure in a HIV/AIDS treatment cohort in Busia, Kenya. PLoS One. 2012;7(11):e49834. doi:10.1371/journal.pone.0049834
   PubMed Web of Science ®Google Scholar
• Bulage L, Ssewanyana I, Nankabirwa V, et al. Factors associated with virological non-suppression among HIV-positive patients on antiretroviral therapy in Uganda, August 2014–July 2015. BMC Infect Dis. 2017;17(1):1–11. doi:10.1186/s12879-017-2428-3
   PubMed Web of Science ®Google Scholar
• Tran DA, Wilson DP, Shakeshaft A, Ngo AD, Doran C, Zhang L. Determinants of virological failure after 1 year’s antiretroviral therapy in Vietnamese people with HIV: findings from a retrospective cohort of 13 outpatient clinics in six provinces. Sex Transm Infect. 2014;90(7):538–544. doi:10.1136/sextrans-2013-051353
   PubMed Web of Science ®Google Scholar
• Ayalew MB, Kumilachew D, Belay A, et al. First-line antiretroviral treatment failure and associated factors in HIV patients at the University of Gondar Teaching Hospital, Gondar, Northwest Ethiopia. HIV/AIDS. 2016;8:141.
   Google Scholar
• Ahmed M, Merga H, Jarso H. Predictors of virological treatment failure among adult HIV patients on first-line antiretroviral therapy in Woldia and Dessie hospitals, Northeast Ethiopia: a case-control study. BMC Infect Dis. 2019;19(1):1–7. doi:10.1186/s12879-019-3924-4
   PubMed Web of Science ®Google Scholar
• Deeks SG, Overbaugh J, Phillips A, Buchbinder S. HIV infection. Nat Rev Dis Primers. 2015;1:15035. doi:10.1038/nrdp.2015.35
   PubMed Web of Science ®Google Scholar
• Chesney MA, Morin M, Sherr L. Adherence to HIV combination therapy. Soc Sci Med. 2000;50(11):1599–1605. doi:10.1016/S0277-9536(99)00468-2
   PubMed Web of Science ®Google Scholar
• Getawa S, Fentahun A, Adane T, Melku M. Antiretroviral treatment failure and associated factors among HIV-infected children on antiretroviral therapy: a retrospective study. HIV/AIDS. 2021;13:229.
   Google Scholar